Stay updated on Sparsentan in IgA Nephropathy: Clinical Trial
Sign up to get notified when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.

Latest updates to the Sparsentan in IgA Nephropathy: Clinical Trial page
- Check2 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the detailed study content with an error screen. Only the minimal header/navigation remains, and the full study information is no longer accessible.SummaryDifference18%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays Revision: v3.6.6, indicating a small system update that replaces the previous v3.6.5. There are no changes to the study details or publicly visible content.SummaryDifference0.0%

- Check30 days agoChange DetectedAdds '2017 ( U.S. NIH Grant/Contract )' to the study's identifiers, indicating NIH funding for the PROTECT trial.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page reflects a newer revision tag (v3.6.5) replacing the prior v3.6.4, indicating an internal update to the page’s documentation or underlying build.SummaryDifference0.0%

- Check59 days agoChange DetectedA new revision tag, Revision: v3.6.4, was added to the page, replacing Revision: v3.6.3 and signaling a small CMS/content update.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision: v3.6.3 was added, replacing v3.6.2. This marks an update to the page revision without altering the study information presented.SummaryDifference0.0%

Stay in the know with updates to Sparsentan in IgA Nephropathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.